The courses and live events offered in 2019 by the Heraeus PALACADEMY provide orthopaedic and trauma surgeons, as well as specialist operating theatre staff, with many continuing education options for modern cementing techniques and infection management in arthroplasty. Registration is now open.
Training for surgical staff
In the ‘Modern cementing techniques’ course, the experts from Heraeus Medical provide a fundamental understanding of PMMA bone cement and its processing and use in arthroplasty. Special attention will be paid to the use of antibiotic-loaded bone cement as a local carrier of active substance for primary surgery and revision arthroplasty. In the practical part of the course, participants practise handling different bone cements and mixing systems.
Surgical staff with experience in revision surgery can deepen and extend their expertise in the course ‘Revision arthroplasty and infection management’. The focus will be on topics such as hygiene measures and antibiotic prophylaxis as well the diagnosis and therapy of periprosthetic infections. A practical workshop and guest presentations by experienced clinicians complete the programme. The format provides ample opportunity for exchange and discussion.
Training events for physicians
The challenging patient and the use of antibiotics in the management of periprosthetic infections are the subjects of the satellite symposia at international scientific conferences. Experts from orthopaedic surgery, infectious disease specialists and microbiologists provide insights into the latest findings.
More information about the courses and registration can be found at PALACADEMY Live Education
Heraeus Medical is a leader in the area of bone cements and biomaterials for surgical orthopaedics and trauma surgery. This enables the company to make an important contribution to supporting surgeons and the surgical team and to improve surgery outcomes. In the area of biomaterials, Heraeus Medical focuses on products for use in bone and joint surgery. The core product PALACOS® is considered the gold standard among bone cements and has repeatedly proven itself for 60 years of clinical use. The first bone cement with antibiotic for infection prophylaxis in endoprosthetics was developed more than 45 years ago with PALACOS® R+G.
The Heraeus technology group based in Hanau is a worldwide leading family-owned portfolio company. The roots of the company founded in 1851 stretch back to a pharmacy run by the family since 1660. Today Heraeus combines a multitude of business lines in the fields of environmental technology, energy, electronics, health, mobility and industrial applications.
In the 2017 financial year Heraeus generated total revenues of 21.8 bn. €. The FORTUNE Global 500 listed company employs a workforce of around 13,000 in 40 countries and holds a leading position in its global sales markets. Heraeus is among the top 10 family-owned companies in Germany.
With technical competence, excellence, as well as a focus on innovation and an entrepreneurial management culture, we aspire to continuously improve our performance. We create high-quality solutions for our customers and sustainably strengthen their competitiveness by connecting unique material competence with technology leadership.